Page last updated: 2024-09-05

isospaglumic acid and Multiple Sclerosis

isospaglumic acid has been researched along with Multiple Sclerosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alt, J; Hollinger, KR; Kaplin, AI; Riehm, AM; Slusher, BS	1
Alt, J; Barker, PB; Brandt, J; Calabresi, PA; Crainiceau, CM; Grishkan, I; Kaplin, AI; Pletnikov, MV; Pomper, MG; Rahn, KA; Rais, R; Rojas, C; Slusher, BS; Stathis, M; Watkins, CC	1
Barker, GJ; Duncan, JS; McLean, MA; Woermann, FG	1

Trials

1 trial(s) available for isospaglumic acid and Multiple Sclerosis

Article	Year
Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magnetic resonance in medicine, 2000, Volume: 44, Issue:3 Topics: Adult; Aspartic Acid; Brain; Brain Chemistry; Calibration; Cerebrospinal Fluid; Choline; Creatine; Dipeptides; Epilepsy; Female; Glutamic Acid; Glutamine; Humans; Inositol; Lactic Acid; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Phantoms, Imaging; Regression Analysis; Sensitivity and Specificity	2000

Article

Year

Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter.

Magnetic resonance in medicine, 2000, Volume: 44, Issue:3

Topics: Adult; Aspartic Acid; Brain; Brain Chemistry; Calibration; Cerebrospinal Fluid; Choline; Creatine; Dipeptides; Epilepsy; Female; Glutamic Acid; Glutamine; Humans; Inositol; Lactic Acid; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Phantoms, Imaging; Regression Analysis; Sensitivity and Specificity

2000

Other Studies

2 other study(ies) available for isospaglumic acid and Multiple Sclerosis

Article	Year
Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis. Brain research, 2016, Mar-15, Volume: 1635 Topics: Animals; Aspartic Acid; Cognition Disorders; Dipeptides; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Glutamate Carboxypeptidase II; Hippocampus; Maze Learning; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Organophosphorus Compounds; Severity of Illness Index	2016
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 2012, Dec-04, Volume: 109, Issue:49 Topics: Adult; Analysis of Variance; Animals; Cognitive Dysfunction; Dipeptides; Encephalomyelitis, Autoimmune, Experimental; Female; Flow Cytometry; Glutamate Carboxypeptidase II; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuropsychological Tests; Organophosphorus Compounds	2012

Article

Year

Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis.

Brain research, 2016, Mar-15, Volume: 1635

Topics: Animals; Aspartic Acid; Cognition Disorders; Dipeptides; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Glutamate Carboxypeptidase II; Hippocampus; Maze Learning; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Organophosphorus Compounds; Severity of Illness Index

2016

Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.

Proceedings of the National Academy of Sciences of the United States of America, 2012, Dec-04, Volume: 109, Issue:49

Topics: Adult; Analysis of Variance; Animals; Cognitive Dysfunction; Dipeptides; Encephalomyelitis, Autoimmune, Experimental; Female; Flow Cytometry; Glutamate Carboxypeptidase II; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuropsychological Tests; Organophosphorus Compounds

2012